Class information for:
Level 1: ONCOLYTIC VIRUS//ONCOLYTIC ADENOVIRUS//VIROTHERAPY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1181 2800 50.2 90%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
419 3       ADENOVIRUS//MERKEL CELL CARCINOMA//GENE THERAPY 28518
564 2             GENE THERAPY//ADENOVIRUS//HUMAN GENE THERAPY 14456
1181 1                   ONCOLYTIC VIRUS//ONCOLYTIC ADENOVIRUS//VIROTHERAPY 2800

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOLYTIC VIRUS authKW 2345599 11% 67% 319
2 ONCOLYTIC ADENOVIRUS authKW 1064764 6% 63% 155
3 VIROTHERAPY authKW 1015681 5% 61% 152
4 ONCOLYTIC authKW 659415 3% 65% 93
5 CANC GENE THER Y GRP address 579578 3% 60% 89
6 ONCOLYTIC VIROTHERAPY authKW 544169 3% 70% 71
7 ONCOLYSIS authKW 509645 3% 64% 73
8 SAN DIEGO SCI address 359517 2% 63% 52
9 CANCER GENE THERAPY journal 259698 8% 11% 216
10 G207 authKW 218567 1% 95% 21

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Medicine, Research & Experimental 28014 37% 0% 1048
2 Oncology 19453 43% 0% 1215
3 Biotechnology & Applied Microbiology 16970 33% 0% 934
4 Genetics & Heredity 14673 31% 0% 856
5 Virology 3743 9% 0% 258
6 Biochemistry & Molecular Biology 240 12% 0% 347
7 Cell Biology 188 6% 0% 177
8 Multidisciplinary Sciences 42 1% 0% 26
9 Mathematical & Computational Biology 34 1% 0% 27
10 Gastroenterology & Hepatology 19 2% 0% 46

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANC GENE THER Y GRP 579578 3% 60% 89
2 SAN DIEGO SCI 359517 2% 63% 52
3 XINYUAN MED BIOTECHNOL 188662 2% 38% 45
4 HUMAN GENE THER Y 157918 4% 15% 99
5 REBECCA JOHN MOO COMPREHENS CANC 150941 1% 46% 30
6 FINNISH MOL MED 143504 1% 42% 31
7 IMMUNOVIROTHER Y 125708 1% 82% 14
8 MOL NEUROSURG 122954 1% 28% 41
9 DARDINGER NEUROONCOL NEUROSCI 122257 1% 42% 27
10 GENE CELL THER Y 101138 1% 27% 35

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER GENE THERAPY 259698 8% 11% 216
2 MOLECULAR THERAPY 165539 8% 7% 232
3 MOLECULAR THERAPY-ONCOLYTICS 135659 1% 44% 28
4 GENE THERAPY 76645 6% 4% 166
5 HUMAN GENE THERAPY 41630 4% 3% 113
6 CURRENT OPINION IN MOLECULAR THERAPEUTICS 16118 1% 4% 36
7 CLINICAL CANCER RESEARCH 12655 5% 1% 132
8 JOURNAL OF GENE MEDICINE 12348 1% 3% 40
9 CURRENT GENE THERAPY 9588 1% 4% 22
10 CANCER RESEARCH 9055 7% 0% 182

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ONCOLYTIC VIRUS 2345599 11% 67% 319 Search ONCOLYTIC+VIRUS Search ONCOLYTIC+VIRUS
2 ONCOLYTIC ADENOVIRUS 1064764 6% 63% 155 Search ONCOLYTIC+ADENOVIRUS Search ONCOLYTIC+ADENOVIRUS
3 VIROTHERAPY 1015681 5% 61% 152 Search VIROTHERAPY Search VIROTHERAPY
4 ONCOLYTIC 659415 3% 65% 93 Search ONCOLYTIC Search ONCOLYTIC
5 ONCOLYTIC VIROTHERAPY 544169 3% 70% 71 Search ONCOLYTIC+VIROTHERAPY Search ONCOLYTIC+VIROTHERAPY
6 ONCOLYSIS 509645 3% 64% 73 Search ONCOLYSIS Search ONCOLYSIS
7 G207 218567 1% 95% 21 Search G207 Search G207
8 ONCOLYTIC VIRAL THERAPY 209062 1% 91% 21 Search ONCOLYTIC+VIRAL+THERAPY Search ONCOLYTIC+VIRAL+THERAPY
9 VIRAL ONCOLYSIS 184935 1% 81% 21 Search VIRAL+ONCOLYSIS Search VIRAL+ONCOLYSIS
10 REOVIRUS 182626 3% 21% 78 Search REOVIRUS Search REOVIRUS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ZHANG, LM , TATSUYA, T , NISHIYAMA, Y , (2016) ONCOTARGET STRATEGIES FOR HERPES SIMPLEX VIRUS-1.CURRENT GENE THERAPY. VOL. 16. ISSUE 2. P. 130 -143 174 77% 0
2 TSUN, A , MIAO, XN , WANG, CM , YU, DC , (2016) ONCOLYTIC IMMUNOTHERAPY FOR TREATMENT OF CANCER.PROGRESS IN CANCER IMMUNOTHERAPY. VOL. 909. ISSUE . P. 241 -283 181 70% 0
3 POL, J , BLOY, N , OBRIST, F , EGGERMONT, A , GALON, J , CREMER, I , ERBS, P , LIMACHER, JM , PREVILLE, X , ZITVOGEL, L , ET AL (2014) TRIAL WATCH ONCOLYTIC VIRUSES FOR CANCER THERAPY.ONCOIMMUNOLOGY. VOL. 3. ISSUE 6. P. - 150 59% 36
4 OTTOLINO-PERRY, K , DIALLO, JS , LICHTY, BD , BELL, JC , MCCART, JA , (2010) INTELLIGENT DESIGN: COMBINATION THERAPY WITH ONCOLYTIC VIRUSES.MOLECULAR THERAPY. VOL. 18. ISSUE 2. P. 251-263 120 82% 71
5 RUSSELL, SJ , PENG, KW , BELL, JC , (2012) ONCOLYTIC VIROTHERAPY.NATURE BIOTECHNOLOGY. VOL. 30. ISSUE 7. P. 658 -670 91 58% 331
6 CODY, JJ , DOUGLAS, JT , (2009) ARMED REPLICATING ADENOVIRUSES FOR CANCER VIROTHERAPY.CANCER GENE THERAPY. VOL. 16. ISSUE 6. P. 473-488 125 76% 45
7 CARSON, J , HADDAD, D , BRESSMAN, M , FONG, Y , (2010) ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN.DRUGS OF THE FUTURE. VOL. 35. ISSUE 3. P. 183-195 119 83% 4
8 PETERS, C , RABKIN, SD , (2015) DESIGNING HERPES VIRUSES AS ONCOLYTICS.MOLECULAR THERAPY-ONCOLYTICS. VOL. 2. ISSUE . P. - 120 68% 5
9 WONG, HH , LEMOINE, NR , WANG, YH , (2010) ONCOLYTIC VIRUSES FOR CANCER THERAPY: OVERCOMING THE OBSTACLES.VIRUSES-BASEL. VOL. 2. ISSUE 1. P. 78-106 133 66% 44
10 ATHERTON, MJ , LICHTY, BD , (2013) EVOLUTION OF ONCOLYTIC VIRUSES: NOVEL STRATEGIES FOR CANCER TREATMENT.IMMUNOTHERAPY. VOL. 5. ISSUE 11. P. 1191 -1206 116 71% 13

Classes with closest relation at Level 1


Rank Class id link
1 3599 ADENOVIRUS//COXSACKIE ADENOVIRUS RECEPTOR//HUMAN GENE THER Y
2 3940 SUICIDE GENE THERAPY//CYTOSINE DEAMINASE//HERPES SIMPLEX VIRUS THYMIDINE KINASE
3 17208 NEWCASTLE DISEASE VIRUS//ACTIVE SPECIFIC IMMUNOTHERAPY ASI//ACTIVE SPECIFIC IMMUNOTHERAPY
4 13477 VESICULAR STOMATITIS VIRUS//VESICULAR STOMATITIS//VSV
5 16830 RAD P53//RECOMBINANT ADENOVIRUS P53//ADENOVIRAL MEDIATED INTERFERON ALPHA
6 25514 HERPES SIMPLEX VIRUS VECTOR//W ROXBURY VA HOSP//HELPER VIRUS FREE PACKAGING
7 28833 GENETIC RADIOTHERAPY//TNFERADE//CARG ELEMENTS
8 3242 E1A//ADENOVIRUS E1A//E4ORF6
9 6997 MOL MED GENE THER Y UNIT//ADENOVIRUS//HELPER DEPENDENT ADENOVIRAL VECTOR
10 27919 GENE THER Y SCI//RECOMBINANT SENDAI VIRUS//HVJ E

Go to start page